Literature DB >> 19756925

Pure mucinous carcinoma with axillary lymph node metastasis in a male breast.

Dimitrios M Dragoumis1, Anthoula S Assimaki, Aris P Tsiftsoglou.   

Abstract

Pure mucinous carcinoma of the male breast is an extremely uncommon malignant breast neoplasm and usually occurs at advanced age. It is characterized by a higher degree of mucus production, a more benign behavior, a lower incidence of metastatic nodal involvement, and a subsequent higher survival rate. We describe such a case of a 59-year-old male, who displayed a gradually growing retroareolar tumor of the right breast. The tumor was well demarcated and had a soft consistency with a gelatinous appearance. Based on the preoperative clinical identification of right axillary lymphadenopathy, the patient eventually underwent right modified radical mastectomy and right axillary nodal dissection. Regarding histological findings, the neoplasm corresponded to a pure mucinous carcinoma with axillary lymph node metastasis. Although lymph node metastasis of pure mucinous carcinoma of the breast is rare, it is essential to perform careful clinical examination when the primary breast mass is suspicious for mucinous carcinoma, because the presence of axillary lymphadenopathy will subsequently define the proper choice of therapeutic strategy.

Entities:  

Mesh:

Year:  2009        PMID: 19756925     DOI: 10.1007/s12282-009-0163-3

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  2 in total

1.  Mucinous carcinoma with axillary lymph node metastasis in a male breast: A case report.

Authors:  Faten Hammedi; Amel Trabelsi; Soumaya Ben Abdelkrim; Lilia Ben Yacoub Abid; Wafa Jomaa; Ahlem Bdioui; Nadia Beizig; Moncef Mokni
Journal:  N Am J Med Sci       Date:  2010-02

2.  Mucinous carcinoma occurring in the male breast.

Authors:  Mitsuaki Ishida; Tomoko Umeda; Yuki Kawai; Tsuyoshi Mori; Yoshihiro Kubota; Hajime Abe; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Tohru Tani; Hidetoshi Okabe
Journal:  Oncol Lett       Date:  2013-12-05       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.